Resources

Read the latest publications supporting VitroScan’s highly translational ex-vivo testing solutions and get in touch for more information on how we can help you de-risk your clinical development!

Posters

VitroScan at SITC 2025: Ex vivo micro-tumor testing identifies patient-specific anti-tumor immune responses to T cell engager ubamatamab

Download

VitroScan at ENA 2025: Bispecific antibody ubamatamab induces patient-specific anti-tumor immune responses in an ex vivo platform for ovarian cancer

Download

VitroScan at ESMO 2025: Chemo Sensitivity Score using an ex vivo 3D micro-tumor testing platform to predict clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer

Download

See more

 

Scientific Publication

Koedoot et al., npj Precision Oncology, 2025

Publication of our study showing that VitroScan's 3D ex vivo micro-tumor testing platform can accurately predict whether an ovarian cancer patient will respond to chemotherapy.

Read more

Home Insights Resources